Skip to main content
Top
Published in: Hepatology International 5/2020

01-09-2020 | Computed Tomography | Original Article

Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury

Authors: Ping Lei, Lan Zhang, Ping Han, Chuansheng Zheng, Qiaoxia Tong, Haitao Shang, Fan Yang, Yu Hu, Xin Li, Yuhu Song

Published in: Hepatology International | Issue 5/2020

Login to get access

Abstract

Background and aims

Liver injury is found in some of patients with COVID-19. Liver injury of COVID-19 patients based on severity grading and abdominal radiological signs have not been reported until now. The aim of our study is to determine clinical profiles of the patients based on severity grading, describe abdominal radiological signs, and investigate the correlations of the severity with clinical profiles and radiological signs.

Methods

This retrospective cohort study included 115 patients with COVID-19 from Jan 2020 to Feb 2020. Medical records of the patients were collected and CT images were reviewed.

Results

Common clinical manifestations of patients with COVID-19 were fever (68.70%), cough (56.52%), fatigue (31.30%); some of them had gastrointestinal symptoms (diarrhea, 12.17%; nausea or vomiting 7.83%; inappetence, 7.83%). Abnormal liver function was observed in some of patients with COVID-19. Significant differences in the levels of AST, albumin,CRP were observed among different groups classified by the severity. Common findings of upper abdominal CT scan were liver hypodensity (26.09%) and pericholecystic fat stranding (21.27%); liver hypodensity was more frequently found in critical cases (58.82%). The severity of COVID-19 correlated with semi-quantitative CT score of pulmonary lesions, CT-quantified liver/spleen attenuation ratio in patients with COVID-19.

Conclusions

Some of the patients with COVID-19 displayed liver damage revealed by liver functional tests and upper abdominal CT imaging, and the severity of COVID-19 patients correlated with some of liver functional tests and CT signs; thus, it will allow an earlier identification of high-risk patients for early effective intervention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–513.CrossRefPubMedPubMedCentral Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–513.CrossRefPubMedPubMedCentral
2.
go back to reference Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 2020;8:e17.PubMedPubMedCentral Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 2020;8:e17.PubMedPubMedCentral
9.
go back to reference Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1722.CrossRefPubMed Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1722.CrossRefPubMed
13.
17.
go back to reference Kan X, Ye J, Rong X, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep 2016;6:37998.CrossRefPubMedPubMedCentral Kan X, Ye J, Rong X, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep 2016;6:37998.CrossRefPubMedPubMedCentral
18.
go back to reference Li X, Yang X, Xu D, et al. Magnetic resonance imaging findings in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Clin Gastroenterol Hepatol 2017;15:955–957.CrossRefPubMed Li X, Yang X, Xu D, et al. Magnetic resonance imaging findings in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Clin Gastroenterol Hepatol 2017;15:955–957.CrossRefPubMed
19.
go back to reference Guo T, Li X, Yang X, et al. Gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome and association with liver function. Sci Rep 2019;9:1231.CrossRefPubMedPubMedCentral Guo T, Li X, Yang X, et al. Gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome and association with liver function. Sci Rep 2019;9:1231.CrossRefPubMedPubMedCentral
20.
go back to reference Chang Y-C, Yu C-J, Chang S-C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome evaluation with thin section CT. Radiology 2005;236:1067–1075.CrossRefPubMed Chang Y-C, Yu C-J, Chang S-C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome evaluation with thin section CT. Radiology 2005;236:1067–1075.CrossRefPubMed
22.
go back to reference Zeb I, Li D, Nasir K, et al. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012;19:811–818.CrossRefPubMedPubMedCentral Zeb I, Li D, Nasir K, et al. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012;19:811–818.CrossRefPubMedPubMedCentral
23.
26.
go back to reference Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033–2040.CrossRefPubMed Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033–2040.CrossRefPubMed
Metadata
Title
Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury
Authors
Ping Lei
Lan Zhang
Ping Han
Chuansheng Zheng
Qiaoxia Tong
Haitao Shang
Fan Yang
Yu Hu
Xin Li
Yuhu Song
Publication date
01-09-2020
Publisher
Springer India
Published in
Hepatology International / Issue 5/2020
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10087-1

Other articles of this Issue 5/2020

Hepatology International 5/2020 Go to the issue